Rainier Investment Management’s Amedisys AMED Stock Holding History

Rainier Investment Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.9M	Sell	36,110 -1,160	-3%	-$61.1K	0.8%	67
2017 Q3	$2.09M	Sell	37,270 -2,920	-7%	-$154K	0.49%	92
2017 Q2	$2.52M	Sell	40,190 -16,320	-29%	-$950K	0.5%	94
2017 Q1	$2.89M	Sell	56,510 -32,510	-37%	-$1.55M	0.31%	126
2016 Q4	$3.79M	Sell	89,020 -45,100	-34%	-$1.92M	0.37%	116
2016 Q3	$6.36M	Buy	134,120 +51,690	+63%	+$2.58M	0.41%	109
2016 Q2	$4.16M	Buy	+82,430	New	+$4.16M	0.2%	152

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rainier Investment Management's AMED Position: Q4 2017 in Review

Rainier Investment Management reduced its Amedisys (AMED) stake by 3.1% in Q4 2017, selling an estimated $61.1K and leaving 36,110 shares worth $1.9M. The position accounts for 0.8% of the portfolio, ranked #67.

Rainier Investment Management first reported a position in AMED in Q2 2016 and has held it in 7 quarters since. The position peaked at $6.36M in Q3 2016. 188 funds tracked by Wall St. Rank hold AMED as of Q4 2017.

Rainier Investment Management held 36,110 shares of Amedisys worth $1.9M as of Q4 2017.
Rainier Investment Management sold 1,160 Amedisys shares in Q4 2017, an estimated $61.1K.
Amedisys made up 0.8% of Rainier Investment Management's portfolio in Q4 2017, its #67 holding.
Rainier Investment Management first reported a position in Amedisys in Q2 2016 and has held it in 7 quarters since.
Rainier Investment Management's Amedisys position peaked at $6.36M in Q3 2016.
188 funds tracked by Wall St. Rank held Amedisys as of Q4 2017.

Based on Rainier Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.